The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Handbook of Experimental Pharmacology.
Meakin, J. W. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310230151026 · Cited by 1,959
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Self-citationTransforming growth factor-beta in disease: the dark side of tissue repair.
Border, W. A., & Ruoslahti, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115821 · Cited by 1,105
Self-citationSuppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346371a0 · Cited by 988
Self-citationUse of Single Voided Urine Samples to Estimate Quantitative Proteinuria
Ginsberg, J. M., Chang, B. S., Matarese, R. A., & Garella, S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312223092503 · Cited by 756
Okuda, S., Languino, L. R., Ruoslahti, E., & Border, W. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114731 · Cited by 546
Self-citationCorrelation of fibrosis and transforming growth factor-beta type 2 levels in the eye.
Connor, T. B., Roberts, A. B., Sporn, M. B., Danielpour, D., Dart, L. L., Michels, R. G., de Bustros, S., Enger, C., Kato, H., & Lansing, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114065 · Cited by 481
Tenascin: cDNA cloning and induction by TGF-beta.
Pearson, C. A., Pearson, D., Shibahara, S., Hofsteenge, J., & Chiquet-Ehrismann, R. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03160.x · Cited by 451
Transforming growth factor-β regulates production of proteoglycans by mesangial cells
Border, W. A., Okuda, S., Languino, L. R., & Ruoslahti, E. (1990) · Kidney International · doi:10.1038/ki.1990.35 · Cited by 363
Self-citationChoi, H. U., Johnson, T. L., Pal, S., Tang, L. H., Rosenberg, L., & Neame, P. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81694-0 · Cited by 235
Cited by
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Self-citationDesmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
Iozzo, R. V. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.609 · Cited by 1,637
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
KJÆR, M. (2004) · Physiological Reviews · doi:10.1152/physrev.00031.2003 · Cited by 1,586
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
Role of tissue stroma in cancer cell invasion
De Wever, O., & Mareel, M. (2003) · The Journal of Pathology · doi:10.1002/path.1398 · Cited by 1,042
Hildebrand, A., Romarís, M., Rasmussen, L. M., Heinegård, D., Twardzik, D. R., Border, W. A., & Ruoslahti, E. (1994) · Biochemical Journal · doi:10.1042/bj3020527 · Cited by 994
Self-citationZiyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Roles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
Verrecchia, F., & Mauviel, A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01641.x · Cited by 666
Extracellular Matrix Metabolism in Diabetic Nephropathy
Mason, R. M., & Wahab, N. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065640.77499.d7 · Cited by 655
The Biology of the Small Leucine-rich Proteoglycans
Iozzo, R. V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.18843 · Cited by 645
Molecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
Branton, M. H., & Kopp, J. B. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00250-6 · Cited by 603
Fibroblast Differentiation in Wound Healing and Fibrosis
Darby, I. A., & Hewitson, T. D. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(07)57004-x · Cited by 600
Ziyadeh, F. N., Sharma, K., Ericksen, M., & Wolf, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117004 · Cited by 597
Expression of connective tissue growth factor in human renal fibrosis
Ito, Y., Aten, J., Bende, R. J., Oemar, B. S., Rabelink, T. J., Weening, J. J., & Goldschmeding, R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00820.x · Cited by 562
Functional and Structural Changes in the Kidney in the Early Stages of Obesity
HENEGAR, J. R., BIGLER, S. A., HENEGAR, L. K., TYAGI, S. C., & HALL, J. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261211 · Cited by 549
Proteoglycans: from structural compounds to signaling molecules
Schaefer, L., & Schaefer, R. M. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0821-y · Cited by 548
Latent transforming growth factor-β: Structural features and mechanisms of activation
Munger, J. S., Harpel, J. G., Gleizes, P.-E., Mazzieri, R., Nunes, I., & Rifkin, D. B. (1997) · Kidney International · doi:10.1038/ki.1997.188 · Cited by 511
The role of epithelial-to-mesenchymal transition in renal fibrosis
Zeisberg, M., & Kalluri, R. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0517-9 · Cited by 507
Iozzo, R. V. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709108551 · Cited by 498
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A., & Border, W. A. (1996) · Nature Medicine · doi:10.1038/nm0496-418 · Cited by 482
Self-citationLeucine-rich repeat glycoproteins of the extracellular matrix
Hocking, A. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90070-1 · Cited by 470
Kizawa, H., Kou, I., Iida, A., Sudo, A., Miyamoto, Y., Fukuda, A., Mabuchi, A., Kotani, A., Kawakami, A., Yamamoto, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1496 · Cited by 468
Induction of Cardiac Fibrosis by Transforming Growth Factor-β1
Lijnen, P. J., Petrov, V. V., & Fagard, R. H. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3032 · Cited by 464
Mechanisms of tissue repair: from wound healing to fibrosis
Mutsaers, S. E., Bishop, J. E., McGrouther, G., & Laurent, G. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00115-x · Cited by 454
IMAI, K., HIRAMATSU, A., FUKUSHIMA, D., PIERSCHBACHER, M. D., & OKADA, Y. (1997) · Biochemical Journal · doi:10.1042/bj3220809 · Cited by 445
Self-citationThe molecular basis of keloid and hypertrophic scar formation
Tuan, T.-L., & Nichter, L. S. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)80541-2 · Cited by 431
Ameye, L., & Young, M. F. (2002) · Glycobiology · doi:10.1093/glycob/cwf065 · Cited by 431
Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity
Schmitt-Gr�ff, A., Desmouli�re, A., Gabbiani, G., Schmitt-Gr�ff, A., & Desmouli�re, A. (1994) · Virchows Archiv · doi:10.1007/bf00193944 · Cited by 426
Wound repair in the context of extracellular matrix
Gailit, J., & Clark, R. A. F. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90099-x · Cited by 426
Expression of transforming growth factor-β isoforms in human glomerular diseases
Yamamoto, T., Noble, N. A., Cohen, A. H., Nast, C. C., Hishida, A., Gold, L. I., & Border, W. A. (1996) · Kidney International · doi:10.1038/ki.1996.65 · Cited by 418
Self-citationTransforming growth factor‐β in stem cells and tissue homeostasis
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018) · Bone Research · doi:10.1038/s41413-017-0005-4 · Cited by 414
Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold
Bülow, R. D., & Boor, P. (2019) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155419849388 · Cited by 406
Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis
Yamamoto, T., Noble, N. A., Miller, D. E., & Border, W. A. (1994) · Kidney International · doi:10.1038/ki.1994.122 · Cited by 405
Self-citationYang, Y.-A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215333 · Cited by 404
Yang, Y.-A., Dukhanina, O. I., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z.-Y., Green, J. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15333 · Cited by 404
López-Casillas, F., Payne, H., Andres, J., & Massagué, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.557 · Cited by 393
Proteoglycans of the extracellular matrix and growth control
Kresse, H., & Schönherr, E. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10030 · Cited by 391
Decorin Is a Biological Ligand for the Epidermal Growth Factor Receptor
Iozzo, R. V., Moscatello, D. K., McQuillan, D. J., & Eichstetter, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4489 · Cited by 382
TGF-β in kidney fibrosis: A target for gene therapy
Border, W. A., & Noble, N. A. (1997) · Kidney International · doi:10.1038/ki.1997.190 · Cited by 379
Self-citationFibroblasts in Mechanically Stressed Collagen Lattices Assume a “Synthetic” Phenotype
Kessler, D., Dethlefsen, S., Haase, I., Plomann, M., Hirche, F., Krieg, T., & Eckes, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101602200 · Cited by 370
Eddy, A. A., Giachelli, C. M., McCulloch, W. T. T. A. O. L., & Liu, E. (1995) · Kidney International · doi:10.1038/ki.1995.218 · Cited by 359
Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
Matsumoto, K., & Nakamura, T. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00717.x · Cited by 353
Loss of MicroRNA-192 Promotes Fibrogenesis in Diabetic Nephropathy
Krupa, A., Jenkins, R., Luo, D. D., Lewis, A., Phillips, A., & Fraser, D. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009050530 · Cited by 348
Transforming growth factor β and the liver
Bissell, M. D., Roulot, D., & George, J. (2001) · Hepatology · doi:10.1053/jhep.2001.28457 · Cited by 348
Immunoregulation by members of the TGFβ superfamily
Chen, W., & ten Dijke, P. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.112 · Cited by 347
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Neel, J.-C., Humbert, L., & Lebrun, J.-J. (2012) · ISRN Molecular Biology · doi:10.5402/2012/381428 · Cited by 345
Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
Li, D., & Friedman, S. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01928.x · Cited by 343
TGF-β in Renal Injury and Disease
Böttinger, E. P. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.02.009 · Cited by 339
Genovese, F., Manresa, A. A., Leeming, D. J., Karsdal, M. A., & Boor, P. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-4 · Cited by 337
Merline, R., Moreth, K., Beckmann, J., Nastase, M. V., Zeng-Brouwers, J., Tralhão, J. G., Lemarchand, P., Pfeilschifter, J., Schaefer, R. M., Iozzo, R. V., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001868 · Cited by 333
George, J., Roulot, D., Koteliansky, V. E., & Bissell, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12719 · Cited by 322
Cellular events in the evolution of experimental diabetic nephropathy
Young, B. A., Johnson, R. J., Alpers, C. E., Eng, E., Gordon, K., Floege, J., Couser, W. G., & Seidel, W. T. S. A. F. S. K. (1995) · Kidney International · doi:10.1038/ki.1995.139 · Cited by 318
Saharinen, J., Hyytiäinen, M., Taipale, J., & Keski-Oja, J. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00010-6 · Cited by 315
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.
Wolf, Y. G., Rasmussen, L. M., & Ruoslahti, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117070 · Cited by 304
Self-citationGurujeyalakshmi, G., & Giri, S. N. (1995) · Experimental Lung Research · doi:10.3109/01902149509050842 · Cited by 303
Targeting renal fibrosis: Mechanisms and drug delivery systems
Nastase, M. V., Zeng-Brouwers, J., Wygrecka, M., & Schaefer, L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.019 · Cited by 302
Role of active and latent transforming growth factor β in bone formation
Bonewald, L. F., & Dallas, S. L. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550312 · Cited by 298
Clouthier, D. E., Comerford, S. A., & Hammer, R. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119815 · Cited by 282
Biological interplay between proteoglycans and their innate immune receptors in inflammation
Frey, H., Schroeder, N., Manon‐Jensen, T., Iozzo, R. V., & Schaefer, L. (2013) · The FEBS Journal · doi:10.1111/febs.12145 · Cited by 274
Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor.
Moscatello, D. K., Santra, M., Mann, D. M., McQuillan, D. J., Wong, A. J., & Iozzo, R. V. (1998) · Journal of Clinical Investigation · doi:10.1172/jci846 · Cited by 272
Demetriou, M., Binkert, C., Sukhu, B., Tenenbaum, H. C., & Dennis, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12755 · Cited by 272
Venstrom, K. A., & Reichardt, L. F. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.11.8370483 · Cited by 269
Extracellular Matrix and Cytokines: A Functional Unit
Schönherr, E., & Hausser, H.-J. (2000) · Journal of Immunology Research · doi:10.1155/2000/31748 · Cited by 268
Dallas, S. L., Miyazono, K., Skerry, T. M., Mundy, G. R., & Bonewald, L. F. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.2.539 · Cited by 267
Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action
Liu, Y. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00451.2003 · Cited by 265
Polypeptide growth factors: targeted delivery systems
Nimni, M. E. (1997) · Biomaterials · doi:10.1016/s0142-9612(97)00050-1 · Cited by 260
Cheng, S., & Lovett, D. H. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64327-1 · Cited by 258
Apoptosis in glomerular sclerosis
Sugiyama, H., Kashihara, N., Makino, H., Yamasaki, Y., & Ota, Z. (1996) · Kidney International · doi:10.1038/ki.1996.14 · Cited by 256
Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis
Lovisa, S., Zeisberg, M., & Kalluri, R. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.06.004 · Cited by 255
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230
The human tri-peptide GHK and tissue remodeling
Pickart, L. (2008) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856208784909435 · Cited by 218
Smooth Muscle α Actin (Acta2) and Myofibroblast Function during Hepatic Wound Healing
Rockey, D. C., Weymouth, N., & Shi, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077166 · Cited by 188
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
Wound healing and regenerative strategies
Nauta, A., Gurtner, G., & Longaker, M. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01787.x · Cited by 78
Zhou, X.-M., Wang, G.-L., Wang, X.-B., Liu, L., Zhang, Q., Yin, Y., Wang, Q.-Y., Kang, J., & Hou, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00904 · Cited by 41
Mochida, Y., Parisuthiman, D., Kaku, M., Hanai, J.-I., Sukhatme, V. P., & Yamauchi, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604787200 · Cited by 34
Metadata
- Authors
- Border, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D., & Ruoslahti, E.
- Venue
- Nature
- Published
- 1992-11
- Volume
- 360
- Issue
- 6402
- Pages
- 361-364
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2017096535
- Cited by
- 974
- References
- 17
- FWCI
- 15.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.